Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.41 USD | +0.71% | +6.02% | +5.22% |
04-24 | Precigen, Inc. to Present Late-Breaking Abstract for Pivotal Phase 2 Study Data for PRGN- 2012 AdenoVerse Immunotherapy | CI |
03-25 | North American Morning Briefing : Tech in Focus on -2- | DJ |
Business Summary
Number of employees: 202
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Exemplar
98.8
%
| 12 | 44.7 % | 6 | 98.8 % | -48.81% |
Biopharmaceuticals
1.2
%
| 15 | 55.3 % | 0 | 1.2 % | -99.50% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 27 | 99.1 % | 6 | 100.0 % | -76.66% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Helen Sabzevari
CEO | Chief Executive Officer | 62 | 19-12-31 |
Harry Thomasian
DFI | Director of Finance/CFO | 62 | 21-09-30 |
Randal Kirk
CHM | Chairman | 70 | 08-01-31 |
Amy Lankford
CTO | Chief Tech/Sci/R&D Officer | - | - |
Rutul Shah
COO | Chief Operating Officer | - | - |
Investor Relations Contact | - | 17-12-31 | |
Jim Shaffer
PRN | Corporate Officer/Principal | - | - |
Rob Russell
HRO | Human Resources Officer | - | - |
Don Lehr
LAW | General Counsel | 49 | 08-12-31 |
Corporate Officer/Principal | 59 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Randal Kirk
CHM | Chairman | 70 | 08-01-31 |
Dean Mitchell
BRD | Director/Board Member | 68 | 09-02-28 |
Jeffrey Perez
PRN | Corporate Officer/Principal | 52 | 14-07-31 |
Fred Hassan
BRD | Director/Board Member | 78 | 16-06-29 |
Jeffrey Kindler
BRD | Director/Board Member | 68 | 11-11-27 |
Cesar Alvarez
BRD | Director/Board Member | 76 | 08-01-31 |
James Turley
BRD | Director/Board Member | 68 | 14-04-15 |
Steven Frank
BRD | Director/Board Member | 64 | 08-01-31 |
Director/Board Member | 56 | 17-04-24 | |
Helen Sabzevari
CEO | Chief Executive Officer | 62 | 19-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 256,398,527 | 219,740,867 ( 85.70 %) | 7,479,431 ( 2.917 %) | 85.70 % |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.22% | 351M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- PGEN Stock
- Company Precigen, Inc.